Aescin serves to protect cell surface architectural abnormalities on 7,12-Dimethylbenz[a] anthracene (DMBA) induced oral carcinogenesis

Abstract

Oral squamous cell carcinoma is the most common malignant tumor of the oral cavity accounting for 90% worldwide, with India representing nearly a third of the overall burden and having the second-most elevated number of cases. Aescin, a pentacyclic triterpenoid saponin blend derived from Aesculus hippocastanum L (horse chestnut) and is being used as herbal remedies, has anti-edematous, anti-inflammatory, and antitumor pharmacodynamic abilities. In the present investigation, Tumors were triggered by applying 0.5% % DMBA orally to the hamster buccal pouch (HBP) thrice a week for 14 weeks, and Aescin was administered orally in the alternative days. We observed, the status of cell surface abnormalities by evaluating the glycoproteins (Mucins), collagen fiber, and muscle fibers via histochemical staining techniques include Periodic acid-schif (PAS) used to hit upon glycogen-inclusive polysaccharides and mucosubstances, Picrosirius red dye collagen staining techniques for the diagnostic domain to study levels of fibrosis in a whole range of inflammation caused by cancer. Masson’s trichrome staining augmented the collagenous fibrous tissue and muscle fibers. Our present results propose that Aescin significantly protects against glycoproteins (Mucins), and collagen breakdown on DMBA induced oral carcinogenesis. We concluded that Aescin significantly protected against cell surface abnormalities in carcinogen-induced buccal pouch experimental oral carcinogenesis.